LUXLung8_2A: LUXLung8, figure 2A
In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials
LUXLung8_2A R Documentation
LUXLung8, figure 2A
Description
Kaplan-Meier digitized data from LUXLung8, figure 2A (PMID 26156651). A reported sample size of 795 for a primary endpoint of PFS in lung cancer.
Usage
LUXLung8_2A
Format
A data frame of 795 observations and 3 variables:
time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (afatinib, erlotinib)
Source
Soria J-C, Felip E, Cobo M, et al. Afatinib versus erlotinib as
second-line treatment of patients with advanced squamous cell
carcinoma of the lung (LUX-Lung 8): an open-label randomised
controlled phase 3 trial. Lancet Oncol 2015; 16: 897–907.
Examples
summary(LUXLung8_2A)
kmplot(LUXLung8_2A)
raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| LUXLung8_2A | R Documentation |
LUXLung8, figure 2A
Description
Kaplan-Meier digitized data from LUXLung8, figure 2A (PMID 26156651). A reported sample size of 795 for a primary endpoint of PFS in lung cancer.
Usage
LUXLung8_2A
Format
A data frame of 795 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0: no event, 1: event) |
|
arm | treatment arms (afatinib, erlotinib) | |
Source
Soria J-C, Felip E, Cobo M, et al. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial. Lancet Oncol 2015; 16: 897–907.
Examples
summary(LUXLung8_2A)
kmplot(LUXLung8_2A)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.